Generic Medicine Info
Hypersensitivity. Patients with hypocalcaemia.
Special Precautions
Skin test should be done before initiating therapy. Heart failure. Renal impairment. Pregnancy and lactation. Children. Monitoring Parameters: Serum electrolytes and Ca.
Adverse Reactions
Endocrine disorders: Diabetogenic effect. Gastrointestinal disorders: GI disturbances, abdominal pain. General disorders and administration site conditions: Inj site inflammation. Nervous system disorders: Dizziness, tingling of the hands, unpleasant taste, tremor. Renal and urinary disorders: Urinary frequency. Skin and subcutaneous tissue disorders: Skin rash. Vascular disorders: Flushing.
Potentially Fatal: Anaphylactic shock.
Drug Interactions
Concurrent use with cardiac glycosides (e.g. digitalis) or Ca-channel blockers requires dosage adjustments of these drugs. May decrease serum concentration of lithium.
Disclaimer: This information is independently developed by CIMS based on calcitonin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in